Review
Open access
Jul 2026
Autophagy in MASLD: A Metabolic and Precision Medicine Perspective
Metabolic dysfunction‐associated steatotic liver disease (MASLD) is the most common chronic liver condition worldwide and a major contributor to cirrhosis and hepatocellular carcinoma (HCC). While metabolic triggers such as obesity and insulin resistance are key drivers of MASLD, growing evidence has identified defects...
A. Cazzaniga, Silvia Frigo, Alessandro Cherubini et al.
· Liver international (Print) · 1 citation